Product Information
INTUNIV ER 3 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.3017 per EA under NDC 54092051702. Its NADAC has been published 261 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the guanfacine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092051702
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022037On Market Since
9/2/2009
Pharmacological Classes
Price Statistics
The NADAC for INTUNIV ER 3 MG TABLET has been published 261 times since Nov 28, 2013, and over the history we have for it it has risen 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3017 per EA |
|---|---|
| All-time high | $9.4079 (Mar 16, 2016) |
| All-time low | $7.7301 (Nov 28, 2013) |
| 52-week high | $9.3704 |
| 52-week low | $9.3017 |
| Median price | $9.3224 |
| Average price | $9.1769 |
| Largest weekly change | +12.0% (Jul 9, 2014) |
| Weeks tracked | 261 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INTUNIV ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INTUNIV ER 3 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $9.3017 per EA (NDC 54092051702), effective Jun 24, 2026.
How has the price of INTUNIV ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for INTUNIV ER 3 MG TABLET has risen 20.3%. It has been tracked across 261 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INTUNIV ER 3 MG TABLET?
Since Nov 28, 2013, the NADAC for INTUNIV ER 3 MG TABLET has ranged from a low of $7.7301 (Nov 28, 2013) to a high of $9.4079 (Mar 16, 2016), with a median of $9.3224 per EA.
Are there cheaper alternatives to INTUNIV ER 3 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GUANFACINE HCL ER 3 MG TABLET, is $0.1713 per EA — about 98% below INTUNIV ER 3 MG TABLET.
Who manufactures INTUNIV ER 3 MG TABLET?
INTUNIV ER 3 MG TABLET (NDC 54092051702) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification